Strategic Value Inflections
Decision quality, from someone who has operated the decisions.
Strategic Value Inflections gives PE deal teams, operating partners, and investment committees a life-sciences read they can act on before an LOI — built by an operator with roughly twenty years of pharma, biotech, and medtech executive experience running the functions being diligenced, not assembled by a team of analysts.
Talk to us before your next LOIDecision quality, made visible.
Every deliverable goes through the same gate-based process SVI uses internally: defined evidence and citation standards, independent verification of anything quantitative, and a red-team review before it reaches you. You're not asked to trust the conclusion — you can see the standard it was held to.
Boutique. Principal-led. Expert in every domain.
SVI is a boutique practice: a principal with roughly twenty years of pharma, biotech, medical device, diagnostics, and radiopharma executive experience — backed by a vetted network of former operators and practitioners across regulatory, clinical, reimbursement, market access, healthcare economics, and IP. Every engagement draws on the specific expertise the deal requires. No analyst hours, no junior team, no partner review layered on at the end.
How we work
Explore the investment questions →Investment Questions
The diligence questions that can actually change an investment decision — scoped around the thesis, not a report template.
Expertise
Operator experience across oncology, radiopharma, CNS, rare disease, devices, and diagnostics — and the functions the diligence draws on.
Selected Experience
Executive responsibility across transactions, R&D, regulatory, commercialization, and operating leadership.
~20 years
Life-sciences executive experience
VP
Roles across Strategy, R&D, Corp Dev, Alliance, Intl & Commercial
$10B+
M&A and BD transactions
5 sectors
Pharma · Biotech · Device · Diagnostics · Radiopharma